LEV102 Topical Gel in Acquired Blepharoptosis

NCT05715346 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Acquired Blepharoptosis

Interventions

DRUG: LEV102 1.0%
DRUG: LEV102 2.0%
DRUG: Vehicle

Sponsor

Levation Pharma, Ltd.